For research use only. Not for therapeutic Use.
WZB117(CAT: I011610) is a small molecule inhibitor that targets the enzyme glutathione S-transferase omega-1 (GSTO1). GSTO1 is a member of the glutathione S-transferase family of enzymes and is involved in the regulation of redox homeostasis and cellular response to oxidative stress. WZB117 has been shown to induce apoptosis in cancer cells and inhibit tumor growth in animal models of cancer. It has potential therapeutic applications in the treatment of cancer and other diseases associated with oxidative stress. WZB117 has been widely used as a research tool to study the role of GSTO1 in cellular signaling pathways and for the development of novel therapeutics.
| Catalog Number | I011610 |
| CAS Number | 1223397-11-2 |
| Synonyms | 3-hydroxy-benzoic acid, (3-fluoro-1,2-phenylene)ester |
| Molecular Formula | C20H13FO6 |
| Purity | ≥95% |
| Target | GLUT |
| Solubility | Soluble in DMSO |
| Storage | Store at -20°C |
| IUPAC Name | [3-fluoro-2-(3-hydroxybenzoyl)oxyphenyl] 3-hydroxybenzoate |
| InChI | InChI=1S/C20H13FO6/c21-16-8-3-9-17(26-19(24)12-4-1-6-14(22)10-12)18(16)27-20(25)13-5-2-7-15(23)11-13/h1-11,22-23H |
| InChIKey | FRSWCCBXIHFKKY-UHFFFAOYSA-N |
| SMILES | C1=CC(=CC(=C1)O)C(=O)OC2=C(C(=CC=C2)F)OC(=O)C3=CC(=CC=C3)O |
